secwatch.observer — SEC 8-K summary
======================================

Issuer:     Intellia Therapeutics, Inc. (NTLA)
CIK:        0001652130
Form:       8-K
Filed at:   2024-02-23T23:59:59+00:00
Accession:  0001193125-24-044690
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intellia Therapeutics expands ATM equity facility from $400M to $750M
---------------------------------------------------------------------

- Intellia increased at-the-market equity offering facility from $400M to $750M via amendment to Jefferies Sales Agreement.
- As of 2/23/24, ~$374M of shares sold; additional $350M authorized under new prospectus supplement.
- Remaining unsold shares under existing prospectus: ~$25.7M.
- Jefferies LLC continues as sales agent, receiving 3.0% of gross proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652130/000119312524044690/0001193125-24-044690-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652130/000119312524044690/d762897d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-044690

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer